Yüklüyor......
Systemic GM-CSF recruits effector T cells into the tumor microenvironment in localized prostate cancer
Granulocytic-macrophage colony-stimulating factor (GM-CSF) is used as an adjuvant in cancer vaccine trials and has the potential to enhance antitumor efficacy with immunotherapy; however, its immunologic effects are not fully understood. Here, we report results from a phase 1 study of neoadjuvant GM...
Kaydedildi:
| Yayımlandı: | Cancer Immunol Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5115633/ https://ncbi.nlm.nih.gov/pubmed/27688020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-16-0042 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|